Sodium oxybate

A primer for pharmacists in the treatment off narcolepsy

Shana Castillo, Kimberley J. Begley, Mark A. Malesker, Chloe Steinshouer

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.

Original languageEnglish
Pages (from-to)547-554
Number of pages8
JournalConsultant Pharmacist
Volume29
Issue number8
DOIs
StatePublished - Aug 1 2014

Fingerprint

Sodium Oxybate
Narcolepsy
Pharmacists
Cataplexy
Nursing
Therapeutics
Pharmacies
Physiologic Monitoring
Therapeutic Uses
Patient Education
Consultants
Physicians
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Cite this

Sodium oxybate : A primer for pharmacists in the treatment off narcolepsy. / Castillo, Shana; Begley, Kimberley J.; Malesker, Mark A.; Steinshouer, Chloe.

In: Consultant Pharmacist, Vol. 29, No. 8, 01.08.2014, p. 547-554.

Research output: Contribution to journalArticle

@article{0b4c57e4673f481597b6c4fb3a01e17f,
title = "Sodium oxybate: A primer for pharmacists in the treatment off narcolepsy",
abstract = "OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.",
author = "Shana Castillo and Begley, {Kimberley J.} and Malesker, {Mark A.} and Chloe Steinshouer",
year = "2014",
month = "8",
day = "1",
doi = "10.4140/TCP.n.2014.547",
language = "English",
volume = "29",
pages = "547--554",
journal = "The Senior care pharmacist",
issn = "2639-9636",
publisher = "American Society of Consultant Pharmacists",
number = "8",

}

TY - JOUR

T1 - Sodium oxybate

T2 - A primer for pharmacists in the treatment off narcolepsy

AU - Castillo, Shana

AU - Begley, Kimberley J.

AU - Malesker, Mark A.

AU - Steinshouer, Chloe

PY - 2014/8/1

Y1 - 2014/8/1

N2 - OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.

AB - OBJECTIVE: The purpose of this report is to describe a 57-year-old man who was admitted to a nursing facility for physical therapy. His home medication list included sodium oxybate. This article will provide the pharmacist with a therapeutic overview of sodium oxybate as well as review the unique processes involved with drug acquisition, dosing, patient education, and monitoring. SETTING: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: Sodium oxybate is the only medication in the United States that has approval for both treatment of cataplexy in narcolepsy and treatment of excessive daytime sleepiness in narcolepsy. Sodium oxybate has many unique properties that cause it to differ from past therapies for cataplexy and excessive daytime sleepiness associated with narcolepsy. CONCLUSION: It is important for pharmacists to understand the therapeutic uses of sodium oxybate and to review the processes for acquisition, dosing, and administration to better assist physicians and patients and improve therapeutic outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84928334995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928334995&partnerID=8YFLogxK

U2 - 10.4140/TCP.n.2014.547

DO - 10.4140/TCP.n.2014.547

M3 - Article

VL - 29

SP - 547

EP - 554

JO - The Senior care pharmacist

JF - The Senior care pharmacist

SN - 2639-9636

IS - 8

ER -